Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionHighPoint Advisor Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
HighPoint Advisor Group LLC closes position in EW / Edwards Lifesciences Corporation

On May 14, 2026 - HighPoint Advisor Group LLC filed a 13F-HR form disclosing ownership of 0 shares of Edwards Lifesciences Corporation (US:EW) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 10,939 shares of Edwards Lifesciences Corporation. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 0 -10,939 -100.00 0 -100.00
2026-02-04 2025-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 10,939 489 4.68 933 14.78 0.0433
2025-11-05 2025-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 10,450 573 5.80 813 5.18 0.0387
2025-08-07 2025-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 9,877 -1,739 -14.97 772 -12.87 0.0410
2025-05-05 2025-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 11,616 -364 -3.04 886 4.36 0.0516
2025-02-12 2024-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 11,980 577 5.06 850 10.26 0.0462
2024-11-04 2024-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 11,403 -1,121 -8.95 770 0.0449
2024-08-08 2024-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 12,524 9 0.07 1 -100.00 0.0476
2024-05-14 2024-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 12,515 -11 -0.09 1 -99.91 0.0749
2024-03-26 2023-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 12,526 -9,995 -44.38 1,167 -47.12 0.0836
2022-08-15 2022-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 22,521 11,408 102.65 2,207 75.44 0.2414
2021-11-15 2021-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 11,113 -193 -1.71 1,258 7.43 0.1232
2021-07-29 2021-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 11,306 674 6.34 1,171 28.12 0.1179
2021-04-12 2021-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 10,632 1,664 18.55 914 18.86 0.1058
2021-02-10 2020-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 8,968 703 8.51 769 19.97 0.0936
2020-11-06 2020-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 8,265 -485 -5.54 641 6.13 0.1160
2020-08-13 2020-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 8,750 5,890 205.94 604 -5.48 0.1291
2020-05-01 2020-03-31 13F/A-2 EDWARDS LIFESCIENCES Common Stock 28176E108 2,860 -2,412 -45.75 639 -49.92 0.1522
2020-04-27 2020-03-31 13F/A-1 EDWARDS LIFESCIENCES Common Stock 28176E108 639 -2,221 3 0.0451
2020-04-27 2020-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 5,272 0 1,276 261,993.4912
2020-02-13 2019-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 5,272 -103 -1.92 1,276 1.43 0.2629
2019-11-12 2019-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 5,375 2,489 86.24 1,258 125.04 0.2780
2019-08-15 2019-06-30 13F/A-1 EDWARDS LIFESCIENCES Common Stock 28176E108 2,886 -24 -0.82 559 7.92 0.1309
2019-08-15 2019-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,910 0 518
2019-05-08 2019-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,910 -3 -0.10 518 0.58 0.1268
2019-02-20 2018-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,913 88 3.12 515 22.04 0.1364
2018-10-23 2018-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,825 -81 -2.79 422 4.20 0.1156
2018-08-20 2018-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,906 9 0.31 405 -2.17 0.1093
2018-06-11 2018-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,897 798 38.02 414 55.06 0.1137
2018-02-15 2017-12-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,099 -302 -12.58 267 9.88 0.0765
2017-11-06 2017-09-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 2,401 -4,273 -64.02 243 -68.65 0.0754
2017-08-15 2017-06-30 13F EDWARDS LIFESCIENCES Common Stock 28176E108 6,674 0 0.00 775 0.00 0.2494
2017-08-07 2017-03-31 13F EDWARDS LIFESCIENCES Common Stock 28176E108 6,674 6,674 775 0.2494
2017-03-02 2016-12-31 13F EDWARD LIFESCIENCES Common Stock 28176E108 0 -2,324 -100.00 0 -100.00
2016-11-21 2016-09-30 13F EDWARD LIFESCIENCES Common Stock 28176E108 2,324 353 17.91 211 -5.38 0.0743
2016-08-10 2016-06-30 13F EDWARD LIFESCIENCES Common Stock 28176E108 1,971 1,971 223 0.0782
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.